Publication Build: This will be filled in by the publication tooling
| Page standards status: Trial-use | Maturity Level: 2 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:ValueSet ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "cmc-comp-section-types-vs"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet cmc-comp-section-types-vs</b></p><a name=\"cmc-comp-section-types-vs\"> </a><a name=\"hccmc-comp-section-types-vs\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.4.0/CodeSystem-ICHContextOfUse.html\"><code>http://terminology.hl7.org/CodeSystem/ICHContextOfUse</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>ich_3.2.s</td><td>m3.2.s drug substance</td></tr><tr><td>ich_3.2.s.1</td><td>m3.2.s.1 general information</td></tr><tr><td>ich_3.2.s.2</td><td>m3.2.s.2 manufacture</td></tr><tr><td>ich_3.2.s.2.1</td><td>m3.2.s.2.1 manufacturer(s)</td></tr><tr><td>ich_3.2.s.2.2</td><td>m3.2.s.2.2 description of manufacturing process and process controls</td></tr><tr><td>ich_3.2.s.2.3</td><td>m3.2.s.2.3 control of materials</td></tr><tr><td>ich_3.2.s.2.4</td><td>m3.2.s.2.4 controls of critical steps and intermediates</td></tr><tr><td>ich_3.2.s.2.5</td><td>m3.2.s.2.5 process validation and/or evaluation</td></tr><tr><td>ich_3.2.s.2.6</td><td>m3.2.s.2.6 manufacturing process development</td></tr><tr><td>ich_3.2.s.3</td><td>m3.2.s.3 characterisation</td></tr><tr><td>ich_3.2.s.3.1</td><td>m3.2.s.3.1 elucidation of structure and other characteristics</td></tr><tr><td>ich_3.2.s.3.2</td><td>m3.2.s.3.2 impurities</td></tr><tr><td>ich_3.2.s.4</td><td>m3.2.s.4 control of drug substance</td></tr><tr><td>ich_3.2.s.4.1</td><td>m3.2.s.4.1 specification</td></tr><tr><td>ich_3.2.s.4.2</td><td>m3.2.s.4.2 analytical procedures</td></tr><tr><td>ich_3.2.s.4.3</td><td>m3.2.s.4.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.s.4.4</td><td>m3.2.s.4.4 batch analyses</td></tr><tr><td>ich_3.2.s.4.5</td><td>m3.2.s.4.5 justification of specification</td></tr><tr><td>ich_3.2.s.5</td><td>m3.2.s.5 reference standards or materials</td></tr><tr><td>ich_3.2.s.6</td><td>m3.2.s.6 container closure system</td></tr><tr><td>ich_3.2.s.7</td><td>m3.2.s.7 stability</td></tr><tr><td>ich_3.2.s.7.1</td><td>m3.2.s.7.1 stability summary and conclusions</td></tr><tr><td>ich_3.2.s.7.2</td><td>m3.2.s.7.2 post-approval stability protocol and stability commitment</td></tr><tr><td>ich_3.2.s.7.3</td><td>m3.2.s.7.3 stability data</td></tr><tr><td>ich_3.2.p</td><td>m3.2.p drug product</td></tr><tr><td>ich_3.2.p.1</td><td>m3.2.p.1 description and composition of the drug product</td></tr><tr><td>ich_3.2.p.2</td><td>m3.2.p.2 pharmaceutical development</td></tr><tr><td>ich_3.2.p.2.1</td><td>m3.2.p.2.1 components of the drug product</td></tr><tr><td>ich_3.2.p.2.2</td><td>m3.2.p.2.2 drug product</td></tr><tr><td>ich_3.2.p.2.3</td><td>m3.2.p.2.3 manufacturing process development</td></tr><tr><td>ich_3.2.p.2.4</td><td>m3.2.p.2.4 container closure system</td></tr><tr><td>ich_3.2.p.2.5</td><td>m3.2.p.2.5 microbiological attributes</td></tr><tr><td>ich_3.2.p.2.6</td><td>m3.2.p.2.6 compatibility</td></tr><tr><td>ich_3.2.p.3</td><td>m3.2.p.3 manufacture</td></tr><tr><td>ich_3.2.p.3.1</td><td>m3.2.p.3.1 manufacturer(s)</td></tr><tr><td>ich_3.2.p.3.2</td><td>m3.2.p.3.2 batch formula</td></tr><tr><td>ich_3.2.p.3.3</td><td>m3.2.p.3.3 description of manufacturing process and process controls</td></tr><tr><td>ich_3.2.p.3.4</td><td>m3.2.p.3.4 controls of critical steps and intermediates</td></tr><tr><td>ich_3.2.p.3.5</td><td>m3.2.p.3.5 process validation and/or evaluation</td></tr><tr><td>ich_3.2.p.4</td><td>m3.2.p.4 control of excipients</td></tr><tr><td>ich_3.2.p.4.1</td><td>m3.2.p.4.1 specifications</td></tr><tr><td>ich_3.2.p.4.2</td><td>m3.2.p.4.2 analytical procedures</td></tr><tr><td>ich_3.2.p.4.3</td><td>m3.2.p.4.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.p.4.4</td><td>m3.2.p.4.4 justification of specifications</td></tr><tr><td>ich_3.2.p.4.5</td><td>m3.2.p.4.5 excipients of human or animal origin</td></tr><tr><td>ich_3.2.p.4.6</td><td>m3.2.p.4.6 novel excipients</td></tr><tr><td>ich_3.2.p.5</td><td>m3.2.p.5 control of drug product</td></tr><tr><td>ich_3.2.p.5.1</td><td>m3.2.p.5.1 specification(s)</td></tr><tr><td>ich_3.2.p.5.2</td><td>m3.2.p.5.2 analytical procedures</td></tr><tr><td>ich_3.2.p.5.3</td><td>m3.2.p.5.3 validation of analytical procedures</td></tr><tr><td>ich_3.2.p.5.4</td><td>m3.2.p.5.4 batch analyses</td></tr><tr><td>ich_3.2.p.5.5</td><td>m3.2.p.5.5 characterisation of impurities</td></tr><tr><td>ich_3.2.p.5.6</td><td>m3.2.p.5.6 justification of specifications</td></tr><tr><td>ich_3.2.p.6</td><td>m3.2.p.6 reference standards or materials</td></tr><tr><td>ich_3.2.p.7</td><td>m3.2.p.7 container closure system</td></tr><tr><td>ich_3.2.p.8</td><td>m3.2.p.8 stability</td></tr><tr><td>ich_3.2.p.8.1</td><td>m3.2.p.8.1 stability summary and conclusion</td></tr><tr><td>ich_3.2.p.8.2</td><td>m3.2.p.8.2 post-approval stability protocol and stability commitment</td></tr><tr><td>ich_3.2.p.8.3</td><td>m3.2.p.8.3 stability data</td></tr><tr><td>ich_3.2.a</td><td>m3.2.a appendices</td></tr><tr><td>ich_3.2.a.1</td><td>m3.2.a.1 facilities and equipment</td></tr><tr><td>ich_3.2.a.2</td><td>m3.2.a.2 adventitious agents safety evaluation</td></tr><tr><td>ich_3.2.a.3</td><td>m3.2.a.3 excipients</td></tr><tr><td>ich_3.2.r</td><td>m3.2 r regional information</td></tr><tr><td>ich_3.3</td><td>m3.3 literature references</td></tr></table></li></ul></div>"^^rdf:XMLLiteral
] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
fhir:value [
a fhir:code ;
fhir:v "brr" ]
] [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ] ;
fhir:value [
a fhir:integer ;
fhir:v 2 ;
( fhir:extension [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom"^^xsd:anyURI ] ;
fhir:value [
a fhir:canonical ;
fhir:v "http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda> ] ] ) ]
] [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"^^xsd:anyURI ] ;
fhir:value [
a fhir:code ;
fhir:v "trial-use" ;
( fhir:extension [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom"^^xsd:anyURI ] ;
fhir:value [
a fhir:canonical ;
fhir:v "http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/pq-cmc-fda/ImplementationGuide/hl7.fhir.us.pq-cmc-fda> ] ] ) ]
] ) ; #
fhir:url [ fhir:v "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/cmc-comp-section-types-vs"^^xsd:anyURI] ; #
fhir:identifier ( [
fhir:system [ fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ] ;
fhir:value [ fhir:v "urn:oid:2.16.840.1.113883.4.642.40.36.48.2" ]
] ) ; #
fhir:version [ fhir:v "2.0.0"] ; #
fhir:name [ fhir:v "CmcCompSectionTypesVS"] ; #
fhir:title [ fhir:v "eCTD sections Terminology"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:experimental [ fhir:v false] ; #
fhir:date [ fhir:v "2025-07-08T07:43:10+00:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "HL7 International / Biomedical Research and Regulation"] ; #
fhir:contact ( [
fhir:name [ fhir:v "HL7 International / Biomedical Research and Regulation" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.hl7.org/Special/committees/rcrim" ] ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "brr@lists.HL7.org" ] ] )
] ) ; #
fhir:description [ fhir:v "Value set of all codes in Code system PQCMC Comp Section Types."] ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
fhir:code [ fhir:v "US" ] ;
fhir:display [ fhir:v "United States of America" ] ] )
] ) ; #
fhir:compose [
( fhir:include [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/ICHContextOfUse"^^xsd:anyURI ] ;
( fhir:concept [
fhir:code [ fhir:v "ich_3.2.s" ] ;
fhir:display [ fhir:v "m3.2.s drug substance" ] ] [
fhir:code [ fhir:v "ich_3.2.s.1" ] ;
fhir:display [ fhir:v "m3.2.s.1 general information" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2" ] ;
fhir:display [ fhir:v "m3.2.s.2 manufacture" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.1" ] ;
fhir:display [ fhir:v "m3.2.s.2.1 manufacturer(s)" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.2" ] ;
fhir:display [ fhir:v "m3.2.s.2.2 description of manufacturing process and process controls" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.3" ] ;
fhir:display [ fhir:v "m3.2.s.2.3 control of materials" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.4" ] ;
fhir:display [ fhir:v "m3.2.s.2.4 controls of critical steps and intermediates" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.5" ] ;
fhir:display [ fhir:v "m3.2.s.2.5 process validation and/or evaluation" ] ] [
fhir:code [ fhir:v "ich_3.2.s.2.6" ] ;
fhir:display [ fhir:v "m3.2.s.2.6 manufacturing process development" ] ] [
fhir:code [ fhir:v "ich_3.2.s.3" ] ;
fhir:display [ fhir:v "m3.2.s.3 characterisation" ] ] [
fhir:code [ fhir:v "ich_3.2.s.3.1" ] ;
fhir:display [ fhir:v "m3.2.s.3.1 elucidation of structure and other characteristics" ] ] [
fhir:code [ fhir:v "ich_3.2.s.3.2" ] ;
fhir:display [ fhir:v "m3.2.s.3.2 impurities" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4" ] ;
fhir:display [ fhir:v "m3.2.s.4 control of drug substance" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4.1" ] ;
fhir:display [ fhir:v "m3.2.s.4.1 specification" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4.2" ] ;
fhir:display [ fhir:v "m3.2.s.4.2 analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4.3" ] ;
fhir:display [ fhir:v "m3.2.s.4.3 validation of analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4.4" ] ;
fhir:display [ fhir:v "m3.2.s.4.4 batch analyses" ] ] [
fhir:code [ fhir:v "ich_3.2.s.4.5" ] ;
fhir:display [ fhir:v "m3.2.s.4.5 justification of specification" ] ] [
fhir:code [ fhir:v "ich_3.2.s.5" ] ;
fhir:display [ fhir:v "m3.2.s.5 reference standards or materials" ] ] [
fhir:code [ fhir:v "ich_3.2.s.6" ] ;
fhir:display [ fhir:v "m3.2.s.6 container closure system" ] ] [
fhir:code [ fhir:v "ich_3.2.s.7" ] ;
fhir:display [ fhir:v "m3.2.s.7 stability" ] ] [
fhir:code [ fhir:v "ich_3.2.s.7.1" ] ;
fhir:display [ fhir:v "m3.2.s.7.1 stability summary and conclusions" ] ] [
fhir:code [ fhir:v "ich_3.2.s.7.2" ] ;
fhir:display [ fhir:v "m3.2.s.7.2 post-approval stability protocol and stability commitment" ] ] [
fhir:code [ fhir:v "ich_3.2.s.7.3" ] ;
fhir:display [ fhir:v "m3.2.s.7.3 stability data" ] ] [
fhir:code [ fhir:v "ich_3.2.p" ] ;
fhir:display [ fhir:v "m3.2.p drug product" ] ] [
fhir:code [ fhir:v "ich_3.2.p.1" ] ;
fhir:display [ fhir:v "m3.2.p.1 description and composition of the drug product" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2" ] ;
fhir:display [ fhir:v "m3.2.p.2 pharmaceutical development" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.1" ] ;
fhir:display [ fhir:v "m3.2.p.2.1 components of the drug product" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.2" ] ;
fhir:display [ fhir:v "m3.2.p.2.2 drug product" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.3" ] ;
fhir:display [ fhir:v "m3.2.p.2.3 manufacturing process development" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.4" ] ;
fhir:display [ fhir:v "m3.2.p.2.4 container closure system" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.5" ] ;
fhir:display [ fhir:v "m3.2.p.2.5 microbiological attributes" ] ] [
fhir:code [ fhir:v "ich_3.2.p.2.6" ] ;
fhir:display [ fhir:v "m3.2.p.2.6 compatibility" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3" ] ;
fhir:display [ fhir:v "m3.2.p.3 manufacture" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3.1" ] ;
fhir:display [ fhir:v "m3.2.p.3.1 manufacturer(s)" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3.2" ] ;
fhir:display [ fhir:v "m3.2.p.3.2 batch formula" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3.3" ] ;
fhir:display [ fhir:v "m3.2.p.3.3 description of manufacturing process and process controls" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3.4" ] ;
fhir:display [ fhir:v "m3.2.p.3.4 controls of critical steps and intermediates" ] ] [
fhir:code [ fhir:v "ich_3.2.p.3.5" ] ;
fhir:display [ fhir:v "m3.2.p.3.5 process validation and/or evaluation" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4" ] ;
fhir:display [ fhir:v "m3.2.p.4 control of excipients" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.1" ] ;
fhir:display [ fhir:v "m3.2.p.4.1 specifications" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.2" ] ;
fhir:display [ fhir:v "m3.2.p.4.2 analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.3" ] ;
fhir:display [ fhir:v "m3.2.p.4.3 validation of analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.4" ] ;
fhir:display [ fhir:v "m3.2.p.4.4 justification of specifications" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.5" ] ;
fhir:display [ fhir:v "m3.2.p.4.5 excipients of human or animal origin" ] ] [
fhir:code [ fhir:v "ich_3.2.p.4.6" ] ;
fhir:display [ fhir:v "m3.2.p.4.6 novel excipients" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5" ] ;
fhir:display [ fhir:v "m3.2.p.5 control of drug product" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.1" ] ;
fhir:display [ fhir:v "m3.2.p.5.1 specification(s)" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.2" ] ;
fhir:display [ fhir:v "m3.2.p.5.2 analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.3" ] ;
fhir:display [ fhir:v "m3.2.p.5.3 validation of analytical procedures" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.4" ] ;
fhir:display [ fhir:v "m3.2.p.5.4 batch analyses" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.5" ] ;
fhir:display [ fhir:v "m3.2.p.5.5 characterisation of impurities" ] ] [
fhir:code [ fhir:v "ich_3.2.p.5.6" ] ;
fhir:display [ fhir:v "m3.2.p.5.6 justification of specifications" ] ] [
fhir:code [ fhir:v "ich_3.2.p.6" ] ;
fhir:display [ fhir:v "m3.2.p.6 reference standards or materials" ] ] [
fhir:code [ fhir:v "ich_3.2.p.7" ] ;
fhir:display [ fhir:v "m3.2.p.7 container closure system" ] ] [
fhir:code [ fhir:v "ich_3.2.p.8" ] ;
fhir:display [ fhir:v "m3.2.p.8 stability" ] ] [
fhir:code [ fhir:v "ich_3.2.p.8.1" ] ;
fhir:display [ fhir:v "m3.2.p.8.1 stability summary and conclusion" ] ] [
fhir:code [ fhir:v "ich_3.2.p.8.2" ] ;
fhir:display [ fhir:v "m3.2.p.8.2 post-approval stability protocol and stability commitment" ] ] [
fhir:code [ fhir:v "ich_3.2.p.8.3" ] ;
fhir:display [ fhir:v "m3.2.p.8.3 stability data" ] ] [
fhir:code [ fhir:v "ich_3.2.a" ] ;
fhir:display [ fhir:v "m3.2.a appendices" ] ] [
fhir:code [ fhir:v "ich_3.2.a.1" ] ;
fhir:display [ fhir:v "m3.2.a.1 facilities and equipment" ] ] [
fhir:code [ fhir:v "ich_3.2.a.2" ] ;
fhir:display [ fhir:v "m3.2.a.2 adventitious agents safety evaluation" ] ] [
fhir:code [ fhir:v "ich_3.2.a.3" ] ;
fhir:display [ fhir:v "m3.2.a.3 excipients" ] ] [
fhir:code [ fhir:v "ich_3.2.r" ] ;
fhir:display [ fhir:v "m3.2 r regional information" ] ] [
fhir:code [ fhir:v "ich_3.3" ] ;
fhir:display [ fhir:v "m3.3 literature references" ] ] ) ] )
] . #
IG © 2021+ HL7 International / Biomedical Research and Regulation. Package hl7.fhir.us.pq-cmc-fda#2.0.0 based on FHIR 5.0.0. Generated 2025-07-08
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change
